» Articles » PMID: 19645454

Kinetic and Structural Investigations of the Allosteric Site in Human Epithelial 15-lipoxygenase-2

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2009 Aug 4
PMID 19645454
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Allosteric regulation of human lipoxygenase (hLO) activity has recently been implicated in the cellular biology of prostate cancer. In the current work, we present isotope effect, pH, and substrate inhibitor data of epithelial 15-hLO-2, which probe the allosteric effects on its mechanistic behavior. The Dk(cat)/KM for 15-hLO-2, with AA and LA as substrate, is large indicating hydrogen atom abstraction is the principle rate-determining step, involving a tunneling mechanism for both substrates. For AA, there are multiple rate determining steps (RDS) at both high and low temperatures, with both diffusion and hydrogen bonding rearrangements contributing at high temperature, but only hydrogen bonding rearrangements contributing at low temperature. The observed kinetic dependency on the hydrogen bonding rearrangement is eliminated upon addition of the allosteric effector, 13-(S)-hydroxyoctadecadienoic acid (13-HODE), and no allosteric effects were seen on diffusion or hydrogen atom abstraction. The (k(cat)/KM)AA/(k(cat)/KM)LA ratio was observed to have a pH dependence, which was fit with a titration curve (pKa = 7.7), suggesting the protonation of a histidine residue, which could hydrogen bond with the carboxylate of 13-HODE. Assuming this interaction, 13-HODE was docked to the solvent exposed histidines of a 15-hLO-2 homology model and found to bind well with H627, suggesting a potential location for the allosteric site. Utilizing d31-LA as an inhibitor, it was demonstrated that the binding of d31-LA to the allosteric site changes the conformation of 15-hLO-2 such that the affinity for substrate increases. This result suggests that allosteric binding locks the enzyme into a catalytically competent state, which facilitates binding of LA and decreases the (k(cat)/KM)AA/(k(cat)/KM)LA ratio. Finally, the magnitude of the 13-HODE KD for 15-hLO-2 is over 200-fold lower than that of 13-HODE for 15-hLO-1, changing the substrate specificity of 15-hLO-2 to 1.9. This would alter the LO product distribution and increase the production of the pro-tumorigenic, 13-HODE, possibly representing a pro-tumorigenic feedback loop for 13-HODE and 15-hLO-2.

Citing Articles

Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach.

Viviani L, Iijima T, Piccirillo E, Rezende L, Alegria T, Netto L J Med Chem. 2024; 68(1):307-323.

PMID: 39700339 PMC: 11726667. DOI: 10.1021/acs.jmedchem.4c01884.


Structural and Functional Biology of Mammalian ALOX Isoforms with Particular Emphasis on Enzyme Dimerization and Their Allosteric Properties.

Zhuravlev A, Gavrilyuk V, Chen X, Aksenov V, Kuhn H, Ivanov I Int J Mol Sci. 2024; 25(22).

PMID: 39596127 PMC: 11593649. DOI: 10.3390/ijms252212058.


Lipoxygenases at the Intersection of Infection and Carcinogenesis.

Amoah A, Pestov N, Korneenko T, Prokhorenko I, Kurakin G, Barlev N Int J Mol Sci. 2024; 25(7).

PMID: 38612771 PMC: 11011848. DOI: 10.3390/ijms25073961.


Identification of the Thermal Activation Network in Human 15-Lipoxygenase-2: Divergence from Plant Orthologs and Its Relationship to Hydrogen Tunneling Activation Barriers.

Ohler A, Taylor P, Bledsoe J, Iavarone A, Gilbert N, Offenbacher A ACS Catal. 2024; 14(7):5444-5457.

PMID: 38601784 PMC: 11003420. DOI: 10.1021/acscatal.4c00439.


Functional Characterization of Mouse and Human Arachidonic Acid Lipoxygenase 15B (ALOX15B) Orthologs and of Their Mutants Exhibiting Humanized and Murinized Reaction Specificities.

Kakularam K, Canyelles-Nino M, Chen X, Lluch J, Gonzalez-Lafont A, Kuhn H Int J Mol Sci. 2023; 24(12).

PMID: 37373195 PMC: 10298594. DOI: 10.3390/ijms241210046.


References
1.
Nakano H, Inoue T, Kawasaki N, Miyataka H, Matsumoto H, Taguchi T . Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action. Bioorg Med Chem. 2000; 8(2):373-80. DOI: 10.1016/s0968-0896(99)00291-6. View

2.
Vane J, Bakhle Y, Botting R . Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38:97-120. DOI: 10.1146/annurev.pharmtox.38.1.97. View

3.
Butler R, Mitchell S, Tindall D, Young C . Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. Cell Growth Differ. 2000; 11(1):49-61. View

4.
Yamamoto S . Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1992; 1128(2-3):117-31. DOI: 10.1016/0005-2760(92)90297-9. View

5.
Tomchick D, Phan P, Cymborowski M, Minor W, Holman T . Structural and functional characterization of second-coordination sphere mutants of soybean lipoxygenase-1. Biochemistry. 2001; 40(25):7509-17. DOI: 10.1021/bi002893d. View